Pune, Maharashtra May 16, 2019 (Issuewire.com) - Global E-Clinical Solutions Industry was valued approximately USD 3.5 billion in 2016, is anticipated to grow at a CAGR of 15.39% by 2025.
Industry growth is attributed to the rising government funding and R&D investments from pharma-biotech companies. Moreover, clinical research studies incur a higher cost and are highly regulated, thus there is a rapid increase in the adoption of cost-effective e clinical solution. Additionally, with the advent of big data and healthcare IT, the global healthcare industry is moving towards centralization of data for faster and better execution of healthcare, anywhere across the globe. The E-Clinical Solutions will enable the effective planning, tracking and execution of the healthcare database across different countries.
Get Free Sample Report@ https://www.globalreportsstore.com/request-sample/11410
The major market players in E-Clinical Solutions Industry are Bio-Optronics, Inc., CRF Health, Datatrak International, Inc., Eclinical Solutions, LLC., ERT Clinical, Maxisit Inc., Medidata Solutions, Inc., Merge Healthcare Incorporated, Systems, Inc., Oracle Corporation, Parexel International Corporations, and others. On the basis of delivery mode, currently, the Industry is dominated by web hosted delivery model. The web-hosted delivery model aids faster and easy accessibility of data and incurs lower cost than on-premise delivery. However, in coming years, cloud-hosted models are expected to grow at the highest CAGR. The Industry growth is primarily driven by the ability of the cloud to flexibly integrate with multiple platforms and the pay as you go model.
In 2016, North America dominates the global E-Clinical Solutions Industry with more than 35% revenue share. The Industry growth is driven by the presence of a large number of pharmaceutical and biotechnology firms in the region. Moreover, there is a significant rise in the number of clinical trials in the region due to increasing support from government funds. However, during the forecast period, Asia Pacific Industry is expected to grow at an accelerating rate. Due to less stringent regulations in many Asian countries, the biotechnology and pharmaceuticals companies across the world are outsourcing clinical trials to the developing countries in the Asia Pacific.
Inquiry Before Buy@ https://www.globalreportsstore.com/send-an-enquiry/11410
By Product:
• Electronic Data Capture and Clinical Data Management Systems
• Clinical Trial Management Systems
• Clinical Analytics Platforms
• Randomization and Trial Supply Management
• Clinical Data Integration Platforms
• Electronic Clinical Outcome Assessment Solutions
• Safety Solutions
• Electronic Trial Master File Systems
• Regulatory Information Management Solutions
• Other E-Clinical Solutions
Delivery Mode:
• Web-Hosted Solutions
• On-Premise Solutions
• Cloud-based(SaaS) Solutions
End User:
• E-Clinical Solutions Industry, Sub Segment Analysis
• Contract Research Organizations
• Medical Device Manufacturers
• Hospitals
• Academic Research Institutes
Directly Purchase This Report at USD 3550: https://www.globalreportsstore.com/checkout/11410
By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
Media Contact
Global RS sales@globalreportsstore.com https://www.globalreportsstore.com/